Growing community of inventors

Mercer Island, WA, United States of America

Richard Daifuku

Average Co-Inventor Count = 2.77

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 28

Richard DaifukuAlexander A Gall (8 patents)Richard DaifukuDmitri S Sergueev (7 patents)Richard DaifukuKevin Harris (4 patents)Richard DaifukuDina Sologub (4 patents)Richard DaifukuLing Li (2 patents)Richard DaifukuAnna S Gall (1 patent)Richard DaifukuDmitri Sergueev (1 patent)Richard DaifukuAnna Stanislav Gall (0 patent)Richard DaifukuRichard Daifuku (11 patents)Alexander A GallAlexander A Gall (46 patents)Dmitri S SergueevDmitri S Sergueev (7 patents)Kevin HarrisKevin Harris (4 patents)Dina SologubDina Sologub (4 patents)Ling LiLing Li (2 patents)Anna S GallAnna S Gall (33 patents)Dmitri SergueevDmitri Sergueev (1 patent)Anna Stanislav GallAnna Stanislav Gall (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Koronis Pharmaceuticals, Inc. (7 from 7 patents)

2. Other (1 from 832,718 patents)

3. Epigenetics Phrama LLC (1 from 1 patent)

4. Epigenetics Pharma LLC (1 from 1 patent)

5. 1,3,5-triazines for Treatment of Viral Diseases (1 from 1 patent)


11 patents:

1. 10479807 - Silylated pyrimidine prodrugs and methods of their use

2. 10071112 - Vitamin E-nucleoside prodrugs

3. 9493500 - Fluorinated pyrimidine analogs and methods of use thereof

4. 8324379 - Prodrugs of heteroaryl compounds

5. 7982034 - Prodrugs of heteroaryl compounds

6. 7772197 - 1,3,5-triazines for treatment of viral diseases

7. 7648967 - Mutagenic nucleoside analogs for the treatment of viral disease

8. 7642247 - 1,3,5-triazines for treatment of viral diseases

9. 7589092 - Prodrugs of heteroaryl compounds

10. 7244717 - Mutagenic nucleoside analogs for the treatment of viral disease

11. 7244732 - Prodrugs of heteroaryl compounds

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…